Is fascin really a useful marker in distinguishing between classical Hodgkin's lymphoma and various types of non-Hodgkin's lymphomas in difficult cases?

Journal of Clinical Pathology

Volumn 63, Issue 7, 2010, Pages 571-574

  Idrees, Romana ^a   Ahmad, Zubair ^a   Qureshi, Asim ^a   Ahsan, Aamir ^a   Pervez, Shahid ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

FASCIN;

ARTICLE; CLINICAL ARTICLE; HODGKIN DISEASE; HUMAN; IMMUNOREACTIVITY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL;

ADOLESCENT; ADULT; AGED; CARRIER PROTEINS; CHILD; DIAGNOSIS, DIFFERENTIAL; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MICROFILAMENT PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77955732557     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.075127     Document Type: Article

References (16)

1. Kureishy N, Sapountzi V, Prag S, et al. Fascins and their roles in cell structure and function. Bioessays 2002;24:350-61. (Pubitemid 34305690)
2. Adams JC, Walt FM. Regulation of differentiation and development by extracellular matrix. Development 1993;117:1183-98.
3. Matsudaira P. Actin crosslinking proteins at the leading edge. Semin Cell Biol 1994;5:165-74. (Pubitemid 124003282)
4. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996;84:345-7.
5. Pinkus GS, Pinkus JL, Longhoff E, et al. Fascin, a sensitive new marker for Reed-Sternberg cells of Hodgkins disease. Evidence for a dendritic or B cell derivation? Am J Pathol 1997;150:543-62.
6. Strauchen JA, Dmitriu-Bono A. Immunopathology of Hodgkin's disease: characterization of Reed-Sternberg cells with monoclonal antibodies. Am J Pathol 1986;123:293-300. (Pubitemid 16072529)
7. Bakshi NA, Finn WG, Schnitzer B, et al. Fascin expression in diffuse large B Cell lymphoma, anaplastic large cell lymphoma and classical Hodgkin's lymphoma. Arch Pathol Lab Med 2007;131:742-7. (Pubitemid 46726135)
8. Gao X, Wa DH. Fascin expression in human epithelial tumors and its clinical significance. Nan Fang Yi Ke Da Xue Xue Bao 2008;28:953-5.
9. Karasavvidou F, Barbanis S, Pappa D, et al. Fascin determination in urothelial carcinomas of the urinary bladder: a marker of invasiveness. Arch Pathol Lab Med 2008;132:1912-15.
10. Iguchi T, Aishima S, Umeda K, et al. Fascin expression in progression and prognosis of hepatocellular carcinoma. J Surg Oncol 2009;100:575-9.
11. Roh YH, Kim YH, Choi HJ, et al. Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gall baldder cancer. J Hepatobiliary Pancreatic Surg 2009;16:315-21.
12. Darnel AD, Behmoaram E, Vollmer RT, et al. Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer. Clin Cancer Res 2009;15:1376-83.
13. Hsu KF, Lin CK, Yu CP, et al. Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma. Dis Esophagus 2009;22:402-8.
14. Onodera M, Zen Y, Harada K, et al. Fascin is involved in tumor necrosis factor-alpha-dependent production of MMP9 in cholangiocarcinoma. Lab Invest 2009;89:1261-74.
15. Fan G, Kotylo P, Neiman RS, et al. Comparison of fascin expression in anaplastic large cell lymphoma and Hodgkin disease. Am J Clin Pathol 2003;119:199-204. (Pubitemid 37047874)
16. Bhargava P, Pantanowitz L, Pinkus GS, et al. Utility of fascin and JunB in distinguishing nodular lymphocyte - predominant from classical lymphocyte-rich Hodgkin lymphoma. Appl Immunohistochem Mol Morphol 2010;18:16-23.